Published in Clinical Trials Week, July 18th, 2005
PEGUS PST provides unique advantages in conducting actual use studies. The company has conducted usage and safety studies for some of world's top pharmaceutical and consumer products corporations. Their robust network of pharmacy and clinical research centers allows them to conduct trials with up to 100,000 patients, though most studies average between 500 and 3,000 subjects.
"Our clients depend on us to provide timely and accurate use and safety information for large populations of subjects in real-world situations," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.